PTC THERAPEUTICS INC (PTCT)

US69366J2006 - Common Stock

24.62  -0.59 (-2.34%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
538.6M
41.44%		698.8M
29.74%		937.822M
34.20%		619.31M
-33.96%
EBITDA
YoY % growth
-310.27M
17.85%		-285.16M
8.09%		14.888M
105.22%		-295.311M
-2,083.55%		N/AN/AN/AN/A
EBIT
YoY % growth
-374.4M
11.11%		-414M
-10.58%		-221.702M
46.45%		-350.889M
-58.27%
Operating Margin
-69.51%-59.24%-23.64%-56.66%
EPS
YoY % growth
-7.43
-13.61%		-7.33
1.35%		-6.54
10.78%		-6.00
8.33%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-1.27
32.64%
Revenue
Q2Q % growth		173.62M
-21.23%
EBITDA
Q2Q % growth		-76.408MN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-68.873M
41.43%		N/AN/AN/AN/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.24
87.30%		0.51-0.75-147.48%
Q3 2023
Q2Q % growth		 -1.76
-15.03%		-1.19-0.57-47.41%
Q2 2023
Q2Q % growth		 -2.66
-24.88%		-1.27-1.39-109.52%
Q1 2023
Q2Q % growth		 -1.88
-5.62%		-1.32-0.56-41.94%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 307.056M
83.43%		327.72M-20.664M-6.31%
Q3 2023
Q2Q % growth		 196.6M
-9.44%		214.4M-17.8M-8.30%
Q2 2023
Q2Q % growth		 213.8M
29.18%		211.13M2.67M1.26%
Q1 2023
Q2Q % growth		 220.4M
48.22%		204.49M15.91M7.78%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.62% 5.94% 2.78% -14.51%
Revenue-0.09% -1.41% 0.75% -7.37%